CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2022	Dec. 31, 2021	Dec. 31, 2020
Cash flows from operating activities:
Net income (loss)	$ 381,915	$ (182,952)	$ (465,605)
Adjustments to reconcile net income (loss) to net cash provided by operating activities
Depreciation, depletion, amortization and accretion expense	470,625	454,123	414,087
Write-down of oil and natural gas properties and other well inventory	0	23,729	268,615
Amortization of deferred financing costs and original issue discount	14,379	13,382	6,804
Equity-based compensation expense	15,953	10,992	8,669
Price risk management activities expense (income)	272,191	419,077	(87,685)
Net cash received (paid) on settled derivative instruments	(425,559)	(290,164)	143,905
Equity method investment income	(14,222)	0	0
Loss (gain) on extinguishment of debt	1,569	13,225	(1,662)
Settlement of asset retirement obligations	(69,596)	(67,988)	(43,933)
Gain on sale of assets	303	(687)	0
Changes in operating assets and liabilities:
Accounts receivable	14,927	(35,396)	(34,645)
Other current assets	(36,545)	(18,901)	35,934
Accounts payable	24,258	(6,261)	27,096
Other current liabilities	73,531	64,800	4,200
Other non-current assets and liabilities, net	(13,990)	14,409	26,143
Net cash provided by operating activities	709,739	411,388	301,923
Cash flows from investing activities:
Exploration, development and other capital expenditures	(323,164)	(293,331)	(362,942)
Cash paid for acquisitions, net of cash acquired	(3,500)	(5,399)	(315,962)
Proceeds from sale of property and equipment, net	1,937	4,983	0
Contributions to equity method investees	(2,250)	0	0
Proceeds from sale of equity method investment	15,000	0	0
Net cash used in investing activities	(311,977)	(293,747)	(678,904)
Cash flows from financing activities:
Proceeds from issuance of common stock	0	0	71,100
Issuance of senior notes	0	600,500	0
Redemption of senior notes and other long-term debt	(18,184)	(356,803)	(5,364)
Proceeds from Bank Credit Facility	85,000	100,000	350,000
Repayment of Bank Credit Facility	(460,000)	(365,000)	(60,000)
Deferred financing costs	(189)	(27,833)	(1,287)
Other deferred payments	0	(7,921)	(11,921)
Payments of finance lease	(25,493)	(21,804)	(17,509)
Employee stock awards tax withholdings	(4,603)	(3,161)	(827)
Net cash provided by (used in) financing activities	(423,469)	(82,022)	324,192
Net increase (decrease) in cash and cash equivalents	(25,707)	35,619	(52,789)
Cash and cash equivalents:
Balance, beginning of period	69,852	34,233	87,022
Balance, end of period	44,145	69,852	34,233
Supplemental non-cash transactions:
Capital expenditures included in accounts payable and accrued liabilities	105,773	45,761	74,957
Debt exchanged for common stock	0	0	35,960
Supplemental cash flow information:
Interest paid, net of amounts capitalized	$ 91,809	$ 68,891	$ 67,443